Dr Natalie Kenny is the founder and CEO of BioGrad. A multi award winner in 2021, Dr Kenny is the current EVA’s Businesswoman of the Year, winner of The Business Desk Top 50 City Region Leader for Liverpool and winner of The Business Desk’s North West Investment Award among many other accolades. As well as 2021’s award triumphs, Dr Kenny has been awarded the 2022 Liverpool Women In Business, Woman of the year Award and is nominated for Awards at both the Northern Power Women Awards and the Northern Leadership Awards for 2022.
Dr Kenny has a rich background in scientific research with experience of working in ‘big pharmaceutical’ research for Pfizer as well as research roles for St George’s School of Medicine based in the Amazon Jungle, St John Hopkins Medical School based in Peru and the University of Extremadura in Spain. Her doctorate from Cranfield University is in the field of Translational Medicine with specialisation in ‘New Therapeutics For Rheumatoid Arthritis And Childhood Leukaemia.’ Throughout her already successful career, Dr Natalie Kenny has also had the chance to work on Neurological research in Cambridge as well as Allergy and Respiratory Diseases research in Kent. With a clear ambition to provide gold standard scientific, laboratory and clinical training to the next generation, Dr Kenny has the technical know-how, career, and life experience to really make a difference to the lives of the future’s scientists and clinicians
Mark is an experienced molecular biology laboratory scientist who has conducted research internationally in DNA:RNA biology, immunology and infectious disease biology. He has a successful history of publishing in high impact journals, as well as working in top level research institutes around the world. He has been the driving force behind the growth and development of BioGrad’s laboratory service over the last 18 months. Mark will project manage and give scientific oversight to the project.
Xiaoxin Li is the Biobank Manager for BioGrad. She has broad experience in biomedical science and bioengineering and focused her Ph.D in the field of cancer biology. Xiaoxin is responsible for day-to-day operations of the stem cell biobank, ensuring that all activities involving procurement, processing, storage and release of biosamples are conducted in strict accordance with the highest regulatory standards. She also oversees the maintenance of the LIMS system to guarantee seamless transitions of different projects, enhancing the profile of the BioGrad biobank through public outreach events.
Dr. Yetunde Adegbite is the senior scientist for stem cell biobanking at BioGrad. She started with BioGrad in our Diagnostics arm in January 2022, and was soon promoted to the position of a senior scientist for stem cell banking. An experienced scientist, she has gathered more than 10 years of experience in scientific research, especially in mammalian cell culture, metabolomics, and mitochondrial research. Dr. Adegbite currently supervises a team of scientists that isolate, test, and cryopreserve stem cells from human and equine cord blood, cord tissue, and placenta for long-term banking
Claire Hetherington joined BioGrad Diagnostics in 2021, firstly as a team supervisor and then as deputy laboratory manager where she was responsible for scientific quality assurance and experimental validation for our UKAS accreditation to ISO15189:2012.
Prior to joining BioGrad, Claire conducted her Ph.D. research in Translational Neuroscience at the University of Aberdeen where she studied motor neuron disease using stem cells derived from patients. She has also worked for Astrazeneca on developing novel immunotherapy biologics using isolated human white blood cells and white blood lines. Currently, she splits her time between our stem cell laboratory and our education department.